Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID
Today, Revvity, Inc., announced the launch of its EONIS™ Q system, a CE-IVD declared platform enabling laboratories in countries that accept the CE marking to adopt molecular testing for spinal muscular...

